METHODS: Scoping review.
METHODS: Three databases were searched and the Preferred Reporting Items for Systematic reviews and Meta Analyses extension for Scoping Reviews (PRISMA-ScR) was used as guidance.
RESULTS: A total of 39 studies were included in the final analysis. Between 2.8 and 100 % of athletes reported their performance being negatively impacted by their menstrual cycle, and the main reason was the occurrence of menstrual cycle symptoms. Additionally, a large variability in the prevalence of menstrual cycle symptoms was reported in the different studies mainly due to methodological differences and recall biases.
CONCLUSIONS: Similarly, as to what has been reported in reviews summarizing performance outcomes during different menstrual cycle phases, this review highlights the high degree of variability between how athletes perceive to be impacted by their menstrual/hormonal contraceptive cycle.
BACKGROUND: The protocol of this scoping review was registered at the Open Science Framework on 14 September 2023 (osf.io/efu9x).
方法:范围审查。
方法:检索了三个数据库,并使用系统评价和Meta分析扩展范围评价的首选报告项目(PRISMA-ScR)作为指导。
结果:共有39项研究纳入最终分析。2.8%至100%的运动员报告说,他们的表现受到月经周期的负面影响。主要原因是月经周期症状的发生。此外,在不同的研究中报告了月经周期症状患病率的巨大差异,这主要是由于方法学差异和回忆偏差.
结论:同样,关于总结不同月经周期阶段表现结果的综述报告,这篇综述强调了运动员认为受月经/激素避孕周期影响的程度之间的高度差异性.
背景:此范围审查的协议于2023年9月14日在开放科学框架(osf.io/efu9x)上注册。